A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Pancreatic Cancer
Conditions
Pancreatic Ductal Adenocarcinoma (PDAC) · G12D Mutated KRAS
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
START- Los Angeles, Los Angeles, California, United States
Contact: Principal Investigator (Navid Hafez, MD)Valkyrie Clinical Trials, Los Angeles, California, United States
Contact: Principal Investigator (David Berz, MD)Moffitt Cancer Center, Tampa, Florida, United States
Contact: Principal Investigator (Dae-Won Kim, MD)Johns Hopkins University, Baltimore, Maryland, United States
Contact: Principal Investigator (Mari Nakazawa, MD)START Midwest, Grand Rapids, Michigan, United States
Contact: Principal Investigator (Sreenivasa Chandana, MD)Washington University, St Louis, Missouri, United States
Contact: Principal Investigator (Kian-Huat Lim, MD)START New Jersey, East Brunswick, New Jersey, United States
Contact: Principal Investigator (Bruno Fang, MD)University of North Carolina, Chapel Hill, North Carolina, United States
Contact: Principal Investigator (Ashwin Somasundaram, MD)Sarah Cannon Research Institute, Nashville, Tennessee, United States
Contact: Principal Investigator (Meredith Pelster, MD)START Dallas, Fort Worth, Texas, United States
Contact: Principal Investigator (Salwan Almutar, MD)MD Anderson Cancer Center, Houston, Texas, United States
Contact: Principal Investigator (Shubham Pant, MD)START- San Antonio, San Antonio, Texas, United States
Contact: Principal Investigator (Drew Rasco, MD)START- Mountain Region, West Valley City, Utah, United States
Contact: Principal Investigator (William McKean, MD)UVA Health, Charlottesville, Virginia, United States
Contact: Principal Investigator (Matthew Reilley, MD)Virginia Cancer Specialists, Fairfax, Virginia, United States
Contact: Principal Investigator (Alexander Spira, MD)UW Health, Madison, Wisconsin, United States
Contact: Principal Investigator (Noelle LoConte, MD)ICON Kurralta Park, Kurralta Park, South Australia, Australia
Contact: Principal Investigator (Carolyn Bampton, MD)ICON Cancer Centre, South Brisbane, Australia
Contact: Principal Investigator (Jermaine Coward, MD)